Origin Agritech (39O1) Stock Price & Analysis
39O1 Stock Chart & Stats
- Day’s Range
- EUR 0.62 - EUR 0.65
- 52-Week Range
- EUR 0.58 - EUR 1.42
- Previous Close
- EUR 0.65
- Volume
- N/A
- Average Volume (3M)
- 0
- Market Cap
- EUR 9.20M
- Enterprise Value
- EUR 14.71M
- Total Cash (Recent Filing)
- EUR 13.37M
- Total Debt (Recent Filing)
- EUR 29.12M
- Price to Earnings (P/E)
- ―
- Beta
- 0.64
- Next Earnings
- Jan 11, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Cost Restructuring
The sharp reduction in operating expenses and narrower losses indicate that restructuring is producing measurable operating leverage. If management sustains these savings while rebuilding commercial capacity, the lower cost base can improve resilience and reduce the revenue scale required to approach break-even.
Breeding Pipeline
A broad breeding pipeline and large germplasm base provide multiple opportunities to develop differentiated corn varieties over time. Continued R&D activity, collaborations with more than 30 breeders and AI-assisted selection could strengthen product depth and support future commercialization if execution remains effective.
Biotech Commercial Readiness
The company has expanded the regulatory, production and organizational infrastructure needed to commercialize agricultural biotechnology. These capabilities can support trait monetization and seed sales beyond traditional breeding, while the consortium and restored facility create channels for converting technology into operating revenue.
Bears Say
Revenue And Profitability Pressure
The revenue contraction and continued gross profit compression show that the commercial model has not yet replaced lost activity with sufficiently profitable product sales. Persistent losses reduce internal funding capacity and make the success of the sales rebuild important to restoring sustainable earnings.
Stressed Balance Sheet
Negative equity and rising debt leave the company with limited financial flexibility and a more fragile capital structure. This can constrain investment in breeding and commercialization, increase dependence on external funding, and heighten refinancing or dilution pressure if operating recovery takes longer than expected.
Regulatory And Execution Dependence
The timing of GMO approvals is outside the company’s direct control, yet commercialization upside depends materially on those decisions. Delays could defer revenue from the biotechnology platform, leaving the company reliant on conventional seed sales and increasing the execution burden on its rebuilt sales organization.
39O1 FAQ
What was Origin Agritech’s price range in the past 12 months?
What is Origin Agritech’s market cap?
When is Origin Agritech’s upcoming earnings report date?
How were Origin Agritech’s earnings last quarter?
Is Origin Agritech overvalued?
Does Origin Agritech pay dividends?
What is Origin Agritech’s EPS estimate?
How many shares outstanding does Origin Agritech have?
What happened to Origin Agritech’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Origin Agritech?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Origin Agritech
Established in 1997 and headquartered in Beijing, China, Origin Agritech Limited is a Chinese firm operating in two primary areas: agricultural biotechnology and an e-commerce platform. Its biotechnology segment focuses on the genetic enhancement and breeding of crop seeds, encompassing the development, production, and distribution of hybrid crop varieties and associated seed technologies. The firm also manages an e-commerce platform that caters to farmers across China, offering a diverse array of goods via online and mobile channels. This selection includes agricultural seeds like corn, rice, and vegetables, along with essential farming inputs such as fertilizers and agricultural chemicals. Additionally, the platform provides food, household items, and other consumer products. Origin Agritech maintains collaboration agreements with esteemed institutions such as the Chinese Academy of Agricultural Sciences, the National Maize Improvement Center, China Agricultural University, and Zhejiang University.
- Sector
- Basicmaterials
- Industry
- Agricultural Inputs
- CEO
- Weibin Yan
- Employees
- 97
- Website
- originagritech.com
- Address
- Origin R&D Center, Beijing, BE, 101119, CN
Origin Agritech (39O1) Earnings & Revenues
39O1 Earnings Call
Earnings Call SentimentNeutral
The call presented a balanced view: clear operational and structural progress (large cuts in G&A, improved operating loss, strengthened biotech credentials, rebuilt sales force, sizable breeding pipeline and targeted variety acquisitions) alongside meaningful near-term challenges (a 31.9% revenue decline, ongoing net loss, modest cash position, higher inventories and dependency on regulatory timing for GMO commercialization). Management emphasized that the company is in the midpoint of a recovery plan and investing in sales and R&D to convert pipeline into revenue, but realization of that upside remains contingent on execution and policy developments.
View all DE:39O1 earnings summariesTechnical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 4 | 13 |
| Technical Analysis | 5 | 4 | 1 |
| Moving Averages | 0 | 0 | 12 |
